Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
89
days
Active targeting strategies for PROTAC delivery in cancer therapy: Advances, challenges, and future perspectives
AuthorsMeihan Liu; Yaoshu Song; Kexin Luo; Yongsheng Zhao; Hongpan Zhang
AffiliationsAffiliated Hospital of North Sichuan Medical College, Nanchong, PR China; Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; Department of Thoracic Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, PR China; North Sichuan Medical College, PR China; North Sichuan Medical College Innovation Centre for Science and Technology, PR China; Key Laboratory of Integrated Precision Diagnosis and Treatment for Solid Tumors, Sichuan Provincial Health Commission
48
days
PCSK9 in the liver metastatic niche: From cholesterol homeostasis to tumor microenvironment reprogramming
AuthorsAnder Martin; Helena García García; Iratxe Bañares; Abdel-Majid Khatib; Iker Badiola
AffiliationsUniversity of Bordeaux, Bordeaux Institute of Oncology (BRIC)-UMR1312, Bordeaux, France; Department of Cell Biology and Histology, University of the Basque Country, B° Sarriena sn, Leioa 48940, Spain
62
days
Bridging the gap between infection and detection: Biological, clinical, and health system contributors to diagnostic delay in HPV-associated cervical cancer
AuthorsBreanna R. Buhay; Jaeson D. Chin; Rachel Y. Han; Mark R. Wakefield; Yujiang Fang
AffiliationsDepartment of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, United States; Department of Surgery, University of Missouri School of Medicine, Columbia, MO 65212, United States; Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO, 65212, United States
211
days
Multiple roles of circRNAs in cervical cancer: From fundamental carcinogenic mechanisms to clinical application prospects
AuthorsMiao Huo; Haitao Zhang; Yan Hua; Hong Qin; Wei Wang
AffiliationsDepartment of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Wuyi Road, Taiyuan, Shanxi Province 030001, China
22
days
Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy
AuthorsZhun You; Zihan Lin; Yu Zhang; Libin Xu; Wen Zhang
AffiliationsThe Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China; Department of Gastrointestinal Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of immunology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Department of Orthopedic Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Beijing Key Laboratory of Cell and Gene Therapy for Digestive System Cancers, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
36
days
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential
AuthorsRuihan Cao; Qianqian Wei; Si-si Yan; Caifeng Gong; Lin-lin Bu; Qiuji Wu
AffiliationsSchool of Medicine, Wuhan University, Wuhan 430062, China; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Provincial Clinical Research Center for Cancer, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan 430071, China; Department of Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, Department of Oral & Maxillofacial - Head Neck Oncology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China
119
days
Translational aspects of Desmoplastic small round cell tumor (DSRCT): An expert consensus paper from the OCTOPUS group
AuthorsSandro Pasquali; Valentina Doldi; Janet M. Shipley; Y.K. Stella Man; Sophie Postel-Vinay; Noé Herbel; Michael T. Meister; Marc van de Wetering; Lucy Métayer; Véronique Minard-Colin; Rita Alaggio; Reineke Schoot; Paul Huang; Daniela Di Carlo; Daniel Orbach; Patrizia Gasparini; Michela Casanova; Andrea Ferrari
AffiliationsMolecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Sarcoma Molecular Pathology Team, Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom; ERC Chromatin Remodeling, DNA Repair and Epigenetics Laboratory, INSERM Unit U981, Gustave Roussy Institute, Villejuif 94805, France; Drug Development Department, Gustave Roussy Institute, Villejuif 94805, France; Faculty of Medicine, Paris-Saclay University, Le Kremlin Bicêtre, France; Sarcoma committee, Gustave Roussy Institute, Villejuif 94805, France; University College of London Cancer Institute, London, UK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Department of Children and Adolescents Oncology, Gustave Roussy, Villejuif, France; Pathology Department, Ospedale Pediatrico Bambino Gesù IRCCS, Roma, Italy; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom; Hematology Oncology Division, Department of Women’s and Children’s Health, University of Padova, Padova, Italy; SIREDO (Care, Innovation & Research in Childhood, Adolescent & Young-Adult Oncology) Oncology Center, Institut Curie, Paris Sciences et Lettres University, Paris, France; Tumor Genomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Paediatric Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy
141
days
Research advances in dual-conversion therapy for hepatocellular carcinoma
AuthorsJingren Shao; Chuangye Han; Tao Peng
AffiliationsDepartment of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, Nanning 530021, China
240
days
Gut microbiome dysbiosis and cancer: A systematic review on the emerging role of probiotics in oncology
AuthorsMarjan Salehi; Andrea Gottardo; Tancredi Didier Bazan Russo; Giulia Bonventre; Lorena Incorvaia; Valerio Gristina; Maria Cristina Trecciola; Antonio Galvano
AffiliationsDepartment of Precision Medicine in Medical, Surgical and Critical Care Area (Me.Pre.C.C.) University of Palermo, Via Liborio Giuffrè 5, Palermo, PA 90127, Italy; Opella Healthcare Italy s.r.l., Viale Europa 11, Origgio, VA 21040, Italy; Department of Chemistry, Materials and Chemical Engineering "Giulio Natta" (DCMC), Polytechnic University of Milan, Piazza Leonardo da Vinci 32, Milano, MI 20133, Italy
48
days
Overcoming immunotherapy resistance in extensive-stage small cell lung cancer: Insights into mechanisms and therapeutic opportunities
AuthorsRuonan Guan; Chenyue Zhang; Juntao Zhang; Shanshan Du; Haoyu Wang; Yulin Zhang; Abdi Aziz Mohamed Abdi; Haiyong Wang
AffiliationsDepartment of Internal Medicine Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Number 440, Ji Yan Road, Jinan 250117, China; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, China; Department of Shandong Second Medical University, 7166 Baotong West Street, Weicheng District, Weifang, Shandong 261053, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days